Literature DB >> 10477386

[Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study II. DNA-ploidy and S-phase fraction].

A Chassevent1, M L Jourdan, M Ferrero-Poüs, M Colonna, S Romain, F Spyratos, H Roth, M Bolla.   

Abstract

As part of a clinical research project, proliferative parameters were studied in primary breast cancer: standardization and technical validation of thymidine kinase (TK), thymidylate synthase (TS) and protein tyrosine kinase (PTK) are described. A total of 633 frozen tumor specimens, available in four institutions, was analyzed in three flow cytometry laboratories for DNA content and percentage of S-phase cells (%S) measurement. 1) The standardization step consisted in developing a common protocol for sample preparation; then, common cell suspensions were analyzed in order to perform an inter-laboratory control. Objective guidelines were elaborated to interpret DNA histograms in breast carcinoma. 2) DNA-aneuploidy was observed in 61% of cases of the retrospective series. Compared with DNA-aneuploid tumors, mean %S was significantly lower in case of DNA-diploidy (respectively: 6.4% and 2.2%, p < 0.001). When compared between the four institutions, %S distributions did not differ significantly. 3) %S is strongly correlated with TK, TS and PTK and high percentages were also observed in high grade tumors or tumor without hormone receptors. These results show that a standardization in using flow cytometers and DNA software allows multicenter studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477386

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  2 in total

1.  Prognostic relevance of DNA flow cytometry in breast cancer revisited: The 25-year experience of the Portuguese Institute of Oncology of Lisbon.

Authors:  António E Pinto; Teresa Pereira; Giovani L Silva; Saudade André
Journal:  Oncol Lett       Date:  2017-02-13       Impact factor: 2.967

2.  Can the centrosome be a marker for DNA ploidy in breast cancer?

Authors:  Rita A Sakr; Jocelyne Fleury; Claudie Prengel; Jean-Francois Bernaudin; Serge Uzan; Roman Rouzier; Emile Darai
Journal:  J Cytol       Date:  2012-04       Impact factor: 1.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.